Back
BridgeBio Pharma Quote, Financials, Valuation and Earnings
7 Stocks to Own Before the 2024 Election
Click the link below to get your copy. FREE
Sell
39
BBIO
BridgeBio Pharma
Last Price:
25.76
Seasonality Move:
12.97%
7 Day Trial
ALL ACCESS PASS
$
7
This New Idea is Set to Shock the World
Click here to learn all the details.BridgeBio Pharma Price Quote
$25.76
BridgeBio Pharma Key Stats
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
Day range:
$24.60 - $25.93
52-week range:
$16.62 - $44.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.95
P/B ratio:
0%
Volume:
1.1M
Avg. volume:
2.4M
1-year change:
47.28%
Market cap:
$4.8B
Revenue:
$9.3M
EPS:
$-3.22
How Much Does BridgeBio Pharma Make?
-
How Much Are BridgeBio Pharma's Sales Annually?
BBIO Revenues are $9.3M -
How Much Profit Does BridgeBio Pharma's Make A Year?
BBIO net income is -$643.2M
Is BridgeBio Pharma Growing As A Company?
-
What Is BridgeBio Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 114.62% -
What Is BridgeBio Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BridgeBio Pharma Stock Price Performance
-
Did BridgeBio Pharma Stock Go Up Last Month?
BridgeBio Pharma share price went down by -8% last month -
Did BBIO's Share Price Rise Over The Last Year?
BBIO share price rose by 47.28% over the past 1 year
What Is BridgeBio Pharma 52-Week High & Low?
-
What Is BridgeBio Pharma’s 52-Week High Share Price?
BridgeBio Pharma has traded as high as $44.32 over the past 52 weeks -
What Is BridgeBio Pharma’s 52-Week Low Share Price?
BridgeBio Pharma has traded as low as $16.62 over the past 52 weeks
BridgeBio Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BridgeBio Pharma?
-
How Much Debt Does BridgeBio Pharma Have?
Total long term debt quarterly is $1.7B -
How Much Cash Does BridgeBio Pharma Have?
Cash and short term investments quarterly total is $519.7M -
What Is BridgeBio Pharma’s Book Value Per Share?
Book value per share is -5.61
Is BridgeBio Pharma Cash Flow Positive?
-
What Is BBIO Cash Flow From Operations?
Cash flow from operations (TTM) is -$602.9M -
What Is BridgeBio Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $580.8M -
What Is BridgeBio Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $64.5M
BridgeBio Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
BBIO return on invested capital is -109.42% -
What Is BridgeBio Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -84.63% -
What Is BBIO Return On Equity?
ROE is a measure of profitability and is 0%
BridgeBio Pharma Earnings Date & Stock Price
-
What Is BridgeBio Pharma's Stock Price Today?
A single share of BBIO can be purchased today for 25.76 -
What Is BridgeBio Pharma’s Stock Symbol?
BridgeBio Pharma trades on the nasdaq under the ticker symbol: BBIO -
When Is BridgeBio Pharma’s Next Earnings Date?
The next quarterly earnings date for BridgeBio Pharma is scheduled on August 2, 2024 -
When Is BBIO's next ex-dividend date?
BridgeBio Pharma's next ex-dividend date is July 7, 2024 -
How To Buy BridgeBio Pharma Stock?
You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BridgeBio Pharma Competitors
-
Who Are BridgeBio Pharma's Competitors?
Below is a list of companies who compete with BridgeBio Pharma or are related in some way:
BridgeBio Pharma Dividend Yield
Data Unavailable
BridgeBio Pharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 77.01% |
| Revenue: | 11461.88% | 152% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 49.46 |
| Upside from Last Price: | 92.01% |